Literature DB >> 27863617

Effectiveness of SP6 (Sanyinjiao) acupressure for relief of primary dysmenorrhea symptoms: A systematic review with meta- and sensitivity analyses.

Ukachukwu Okoroafor Abaraogu1, Sylvester Emeka Igwe2, Chidinma Samantha Tabansi-Ochiogu3.   

Abstract

We reviewed the available evidence for SP6 (Sanyinjiao) acupressure for the relief of primary dysmenorrhea (PD) symptoms, as well as patients' experiences of this intervention. We searched six relevant databases and gray literature for publications dated up to March 2016. The search yielded 72 potential studies. Six of these studies, contributing a total of 461 participants, were included in this review. The primary outcome was pain intensity. Studies with significant homogeneity were pooled for meta-analysis. Qualitative data and quantitative data not suitable for meta-analysis were presented as a narrative synthesis. The Cochrane criteria demonstrated that the included studies were generally of low quality with a high risk of bias. SP6 acupressure delivered by trained personnel significantly decreased pain intensity immediately after the intervention (effect size = -0.718; CI = -0.951 to -0.585; p = 0.000), and pain relief remained up to 3 h after the intervention (effect size = -0.979; CI = -1.296 to 0.662; p = 0.000). However, patient-administered intervention required multiple monthly cycles to effect pain reduction. SP6 acupressure appears to be effective when delivered by trained personnel for some PD symptoms. Findings suggest that self-administered acupressure shows promise for the alleviation of PD symptoms. High-quality research is needed before conclusive recommendations are proposed.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dysmenorrhea pain; Primary dysmenorrhea; SP6 acupressure; Sanyinjiao acupressure

Mesh:

Year:  2016        PMID: 27863617     DOI: 10.1016/j.ctcp.2016.09.003

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  7 in total

1.  Electroacupuncture is Beneficial for Primary Dysmenorrhea: The Evidence from Meta-Analysis of Randomized Controlled Trials.

Authors:  Si-Yi Yu; Zheng-Tao Lv; Qing Zhang; Sha Yang; Xi Wu; You-Ping Hu; Fang Zeng; Fan-Rong Liang; Jie Yang
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-05       Impact factor: 2.629

2.  A comparison of the efficacy and safety of complementary and alternative therapies for the primary dysmenorrhea: A network meta-analysis protocol.

Authors:  Fengting Zhai; Dongmei Wang; Zhen Hua; Yuting Jiang; Dandan Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 3.  Integrating Lifestyle Focused Approaches into the Management of Primary Dysmenorrhea: Impact on Quality of Life.

Authors:  Orestis Tsonis; Fani Gkrozou; Zoi Barmpalia; Annamaria Makopoulou; Vassiliki Siafaka
Journal:  Int J Womens Health       Date:  2021-03-17

4.  A systematic review of Tuina for women with primary dysmenorrhea: A protocol for systematic review and meta-analysis.

Authors:  Yueming Lv; Huichao Feng; Fushi Jing; Yonghui Ren; Qian Zhuang; Jiao Rong; Qi Pan; Mengtian Li; Jing Zhang; Fujie Jing
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

5.  Acupuncture modulates the frequency-specific functional connectivity density in primary dysmenorrhea.

Authors:  Li-Ying Liu; Xiang Li; Zi-Lei Tian; Qi Zhang; Zhi-Fu Shen; Wei Wei; Xiao-Li Guo; Ling Chen; Meng-Hua Su; Lu Yang; Si-Yi Yu; Jie Yang
Journal:  Front Neurosci       Date:  2022-08-16       Impact factor: 5.152

6.  Regulation of Mild Moxibustion on Uterine Vascular and Prostaglandin Contents in Primary Dysmenorrhea Rat Model.

Authors:  Xuemei Li; Sha Guo; Zhaoheng Chen; Kuiyu Ren; Hong Zhang; Shuguang Yu; Sha Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-10       Impact factor: 2.629

7.  Assessment of clinical efficacy of traditional Chinese medicine for the management of primary dysmenorrhea in the UK: A protocol of systematic review.

Authors:  Ming-Ming Fu; Xiang-Dong Meng
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.